Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

glioblastoma

  • Open Access
    Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition
    Can Xu, Pengyu Hou, Xiang Li, Menglin Xiao, Ziqi Zhang, Ziru Li, Jianglong Xu, Guoming Liu, Yanli Tan and Chuan Fang
    Cancer Biology & Medicine May 2024, 21 (5) 363-381; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0510
  • Open Access
    Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen and Ming Chen
    Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0373
  • You have access
    Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
    Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
    Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  • You have access
    Expert opinion on translational research for advanced glioblastoma treatment
    Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
    Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
  • You have access
    Development of glioblastoma organoids and their applications in personalized therapy
    Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
    Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061
  • You have access
    Targeting PP2A for cancer therapeutic modulation
    Halle Ronk, Jared S. Rosenblum, Timothy Kung and Zhengping Zhuang
    Cancer Biology & Medicine October 2022, 19 (10) 1428-1439; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0330
  • You have access
    Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
    Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
    Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  • You have access
    Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
    Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
    Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  • You have access
    Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
    Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang
    Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
  • You have access
    BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
    Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu
    Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096

Pages

  • Next
  • 1
  • 2

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire